Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive?
作者信息
Gleeson Dermot, Walmsley Martine, Trivedi Palak J, Joshi Deepak, Rea Ben
机构信息
Liver Unit, Sheffield Teaching Hospitals Sheffield UK, Sheffield, UK.
PSC Support, Oxford, UK.
出版信息
Frontline Gastroenterol. 2022 Aug 4;14(2):162-166. doi: 10.1136/flgastro-2022-102172. eCollection 2023.
Abstract
摘要
相似文献
1
Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive?原发性硬化性胆管炎患者胆管癌的监测：我们能否更积极主动？
Frontline Gastroenterol. 2022 Aug 4;14(2):162-166. doi: 10.1136/flgastro-2022-102172. eCollection 2023.
2
Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.对原发性硬化性胆管炎未选定个体进行胆管癌的前瞻性监测。
J Hepatol. 2023 Mar;78(3):604-613. doi: 10.1016/j.jhep.2022.11.011. Epub 2022 Nov 19.
3
Cholangiocarcinoma complicating primary sclerosing cholangitis.胆管癌合并原发性硬化性胆管炎。
Ann Surg. 1991 Jan;213(1):21-5. doi: 10.1097/00000658-199101000-00004.
4
Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.p53和增殖细胞核抗原在胆管癌及原发性硬化性胆管炎中的表达
Mod Pathol. 2000 Dec;13(12):1265-8. doi: 10.1038/modpathol.3880231.
5
Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.原发性硬化性胆管炎中胆管癌的诊断与管理
J Gastrointest Surg. 1999 Jul-Aug;3(4):357-67; discussion 367-8. doi: 10.1016/s1091-255x(99)80051-1.
6
Sclerosing cholangitis.硬化性胆管炎
Curr Opin Gastroenterol. 2006 May;22(3):288-93. doi: 10.1097/01.mog.0000218966.78558.67.
7
IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.无自身免疫性胰腺炎的IgG4相关性硬化性胆管炎，酷似肝外胆管癌。
Scand J Gastroenterol. 2015 Apr;50(4):447-53. doi: 10.3109/00365521.2014.962603. Epub 2015 Jan 30.
8
Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience.胆管癌合并原发性硬化性胆管炎：24年的经验
Dig Surg. 2008;25(2):126-32. doi: 10.1159/000128169. Epub 2008 Apr 29.
9
Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.原发性硬化性胆管炎相关胆管癌中的9号染色体短臂21区缺失及p16基因失活
J Surg Res. 1999 Jun 1;84(1):88-93. doi: 10.1006/jsre.1999.5615.
10
Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.原发性硬化性胆管炎的 MRI 和 MR 胆胰管成像报告标准：国际原发性硬化性胆管炎研究组磁共振工作组指南。
Eur Radiol. 2022 Feb;32(2):923-937. doi: 10.1007/s00330-021-08147-7. Epub 2021 Aug 6.
引用本文的文献
1
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study.原发性硬化性胆管炎中胆汁游离DNA的突变分析：一项初步研究。
Liver Int. 2025 Apr;45(4):e70049. doi: 10.1111/liv.70049.
本文引用的文献
1
Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies.原发性硬化性胆管炎与癌症、心血管疾病和全因死亡率的关系：队列研究的系统评价和荟萃分析。
Sci Rep. 2021 May 20;11(1):10646. doi: 10.1038/s41598-021-90175-w.
2
Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis.原发性硬化性胆管炎的磁共振成像与超声早期胆管癌检测。
Hepatology. 2021 May;73(5):1868-1881. doi: 10.1002/hep.31575. Epub 2021 Apr 19.
3
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.在原发性硬化性胆管炎患者中检测胆管癌——DNA甲基化和分子生物标志物的前景
JHEP Rep. 2020 Jul 11;2(5):100143. doi: 10.1016/j.jhepr.2020.100143. eCollection 2020 Oct.
4
The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them.原发性硬化性胆管炎（PSC）健康研究：了解患有 PSC 患者及其支持者的心理困扰。
PLoS One. 2020 Jul 6;15(7):e0234624. doi: 10.1371/journal.pone.0234624. eCollection 2020.
5
Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.原发性硬化性胆管炎对炎症性肠病患者癌症和死亡风险的影响，基于性别、种族和年龄。
Gastroenterology. 2020 Sep;159(3):915-928. doi: 10.1053/j.gastro.2020.05.049. Epub 2020 May 20.
6
Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland.原发性硬化性胆管炎的流行病学、恶性肿瘤风险及患者生存率：芬兰一项基于人群的研究
Scand J Gastroenterol. 2020 Jan;55(1):74-81. doi: 10.1080/00365521.2019.1707277. Epub 2020 Jan 4.
7
Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.原发性硬化性胆管炎（PSC）患者的胆管癌：全面综述。
Clin Rev Allergy Immunol. 2020 Feb;58(1):134-149. doi: 10.1007/s12016-019-08764-7.
8
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.AGA 临床实践更新：原发性硬化性胆管炎患者肝胆癌监测：专家综述。
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2416-2422. doi: 10.1016/j.cgh.2019.07.011. Epub 2019 Jul 12.
9
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.英国胃肠病学会和英国PSC 指南：原发性硬化性胆管炎的诊断和管理。
Gut. 2019 Aug;68(8):1356-1378. doi: 10.1136/gutjnl-2018-317993. Epub 2019 Jun 1.
10
Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.将下一代测序技术整合到经内镜逆行胰胆管造影术（ERCP）获得的胆汁标本中，可提高恶性胆管狭窄患者的检出率和诊治水平。
Gut. 2020 Jan;69(1):52-61. doi: 10.1136/gutjnl-2018-317817. Epub 2019 Apr 10.
Zotero 插件